Antagonism of cisplatin induced emesis in the dog
Gylys, J.A.; Doran, K.M.; Buyniski, J.P.
Research Communications in Chemical Pathology and Pharmacology 23(1): 61-68
1979
ISSN/ISBN: 0034-5164 PMID: 441517 Document Number: 346
Cisplatin (cis-diammine-dichloro-platinum) (1 mg/kg s.c.) failed to demonstrate any significant activity. A relationship between antagonism patterns of emetic responses induced by cisplatin and apomorphine was discussed.
Document emailed within 1 workday
Related Documents
Blower, P.R. 1990: The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis European Journal of Cancer 26(Suppl 1): S8-11Li, Y.T.; Mau, Y.K.; Hsu, K.P. 1991: Control of cisplatin-induced delayed emesis Zhonghua Yi Xue Za Zhi 48(6): 451-455
Roila, F.; Ballatori, E.; Del Favero, A. 1999: Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist New England Journal of Medicine 340(24): 1926-1928
Ito, J.; Okada, M.; Abo, T.; Okamoto, Y.; Yamashita, T.; Takahashi, K. 1987: Experimental study on the control of cisplatin-induced emesis in dogs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 1): 706-710
Roila, F.; Tonato, M.; Ballatori, E.; Del Favero, A. 1992: Prevention of cisplatin-induced emesis. The Italian Group for Antiemetic Research Lancet 340(8825): 972
Voravud, N.; Suwanrusmee, H. 2000: Phase II trial of tropisetron and dexamethasone in the prevention of cisplatin-induced emesis Journal of the Medical Association of Thailand 83(6): 668-675
Bhandari, P.; Gupta, Y.K.; Seth, S.D. 1989: BRL 43694, a new 5HT3 receptor antagonist, prevents cisplatin-induced emesis in dogs Methods and Findings in Experimental and Clinical Pharmacology 11(5): 361-363
Agostinucci, W.A.; Gannon, R.H.; Golub, G.R.; Martin, R.S.; Schauer, P.K.; Dinonno, E.B. 1988: Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis Clinical Pharmacy 7(6): 454-457
Cupissol, D.R.; Serrou, B.; Caubel, M. 1990: The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis European Journal of Cancer 26(Suppl 1): S23-S27
Tantipalakorn, C.; Srisomboon, J.; Thienthong, H.; Pantusart, A.; Suprasert, P.; Saereesongkhun, C.; Eamtang, S.; Sutthichat, A.; Pautad, N. 2004: Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial Journal of the Medical Association of Thailand 87(2): 119-125
Garcia-del-Muro, X.; Vadell, C.; Pérez Manga, G.; Bover, I.; Rifá, J.; Beltrán, M.; Barros, M.M.; Germá, J.R.; Fabregat, X.; Moreno, V.; Salvador, A.; Viladiu, P. 1998: Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis European Journal of Cancer 34(1): 193-195
Huo, M.L.; Wang, Y.S.; Wang, P.; Xiang, Y.S.; Wang, J.G. 1986: Emesis induced by cisplatin and sulfato-1, sulfato-1,2-diaminocyclohexane platinum in dogs and their antiemetics Zhongguo Yao Li Xue Bao 7(2): 182-184
Hellenbrecht, D.; Saller, R. 1986: Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis Arzneimittel-Forschung 36(12): 1845-1849
Manusirivithaya, S.; Chareoniam, V.; Isariyodom, P.; Sungsab, D. 2001: Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis Journal of the Medical Association of Thailand 84(7): 966-972
Heron, J.F. 1995: Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone Seminars in Oncology 22(4 Suppl. 10): 24-30
Gandara, D.R.; Harvey, W.H.; Monaghan, G.G.; Perez, E.A.; Stokes, C.; Bryson, J.C.; Finn, A.L.; Hesketh, P.J. 1992: The delayed-emesis syndrome from cisplatin: phase IIi evaluation of ondansetron versus placebo Seminars in Oncology 19(4 Suppl 10: 67-71
Kobayashi, H. 1985: Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity Nihon Sanka Fujinka Gakkai Zasshi 37(6): 888-896
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Yu, Y.; Zhang, X.; Tian, H.; Zhang, Z.; Tian, Y. 2018: Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy Journal of BUON: Official Journal of the Balkan Union of Oncology 23(5): 1396-1401
Roila, F.; Ciccarese, G.; Palladino, M.A.; De Angelis, V. 1998: Prevention of radiotherapy-induced emesis Tumori 84(2): 274-278